omniture
logo
Search
Anbogen Therapeutics, Inc.
Media Room

Latest News

rss

Anbogen Announces Drug Supply Collaboration with BeiGene to Evaluate Combination Therapy in Colorectal Cancer

TAIPEI, Sept. 27, 2024 /PRNewswire/ -- Anbogen, a clinical-stage biotech company, today announced a...

2024-09-27 16:00 1549

Anbogen Secures 12.5 Million in Series A Funding, Advancing Precision Oncology Drug Development

TAIPEI, Jan. 31, 2024 /PRNewswire/ -- Anbogen Therapeutics, a clinical-stage biotechnology company ...

2024-02-01 00:00 1652

AnBogen Therapeutics Receives Approval from U.S. FDA for Phase Ib/II Protocol Amendment for ABT-101

 An oral Tyrosine Kinase Inhibitor of HER2 Exon20 Insertion, for the Treatment of Non-Small Cell Lu...

2022-09-13 22:00 2043